488 related articles for article (PubMed ID: 21705950)
1. Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses.
Reicher S; Boyar FZ; Albitar M; Sulcova V; Agersborg S; Nga V; Zhou Y; Li G; Venegas R; French SW; Chung DS; Stabile BE; Eysselein VE; Anguiano A
Pancreas; 2011 Oct; 40(7):1057-62. PubMed ID: 21705950
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer.
Salek C; Benesova L; Zavoral M; Nosek V; Kasperova L; Ryska M; Strnad R; Traboulsi E; Minarik M
World J Gastroenterol; 2007 Jul; 13(27):3714-20. PubMed ID: 17659731
[TBL] [Abstract][Full Text] [Related]
3. The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies.
Fuccio L; Hassan C; Laterza L; Correale L; Pagano N; Bocus P; Fabbri C; Maimone A; Cennamo V; Repici A; Costamagna G; Bazzoli F; Larghi A
Gastrointest Endosc; 2013 Oct; 78(4):596-608. PubMed ID: 23660563
[TBL] [Abstract][Full Text] [Related]
4. KRAS mutation testing on all non-malignant diagnosis of pancreatic endoscopic ultrasound-guided fine-needle aspiration biopsies improves diagnostic accuracy.
Trisolini E; Armellini E; Paganotti A; Veggiani C; Bozzola C; Frattini M; Pizio C; Mancuso G; Andorno S; Boldorini R
Pathology; 2017 Jun; 49(4):379-386. PubMed ID: 28450086
[TBL] [Abstract][Full Text] [Related]
5. Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma.
Eloubeidi MA; Jhala D; Chhieng DC; Chen VK; Eltoum I; Vickers S; Mel Wilcox C; Jhala N
Cancer; 2003 Oct; 99(5):285-92. PubMed ID: 14579295
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with a KRAS mutation assay using allelic discrimination improves the diagnosis of pancreatic cancer.
Bournet B; Selves J; Grand D; Danjoux M; Hanoun N; Cordelier P; Buscail L
J Clin Gastroenterol; 2015 Jan; 49(1):50-6. PubMed ID: 24798941
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses.
Khalid A; Nodit L; Zahid M; Bauer K; Brody D; Finkelstein SD; McGrath KM
Am J Gastroenterol; 2006 Nov; 101(11):2493-500. PubMed ID: 17029619
[TBL] [Abstract][Full Text] [Related]
8. K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma.
Sekita-Hatakeyama Y; Nishikawa T; Takeuchi M; Morita K; Takeda M; Hatakeyama K; Nakai T; Uchiyama T; Itami H; Fujii T; Mitoro A; Sho M; Ohbayashi C
PLoS One; 2018; 13(3):e0193692. PubMed ID: 29494669
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic ultrasound guided fine needle aspiration with fluorescence in situ hybridization analysis in 104 patients with pancreatic mass.
Ribeiro A; Peng J; Casas C; Fan YS
J Gastroenterol Hepatol; 2014 Aug; 29(8):1654-8. PubMed ID: 24628622
[TBL] [Abstract][Full Text] [Related]
10. Role of repeated endoscopic ultrasound-guided fine needle aspiration in small solid pancreatic masses with previous indeterminate and negative cytological findings.
Tadic M; Kujundzic M; Stoos-Veic T; Kaic G; Vukelic-Markovic M
Dig Dis; 2008; 26(4):377-82. PubMed ID: 19188731
[TBL] [Abstract][Full Text] [Related]
11. Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass.
Maluf-Filho F; Kumar A; Gerhardt R; Kubrusly M; Sakai P; Hondo F; Matuguma SE; Artifon E; Monteiro da Cunha JE; César Machado MC; Ishioka S; Forero E
J Clin Gastroenterol; 2007; 41(10):906-10. PubMed ID: 18090159
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses.
Ogura T; Yamao K; Sawaki A; Mizuno N; Hara K; Hijioka S; Niwa Y; Tajika M; Kondo S; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
Gastrointest Endosc; 2012 Apr; 75(4):769-74. PubMed ID: 22284089
[TBL] [Abstract][Full Text] [Related]
13. Repeated endoscopic ultrasound guided fine needle aspiration (EUS-FNA) improved diagnostic yield of inconclusive initial cytology for suspected pancreatic cancer and unknown intra-abdominal lymphadenopathy.
Prachayakul V; Sriprayoon T; Asawakul P; Pongprasobchai S; Pausawasdi N; Kachintorn U
J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S68-74. PubMed ID: 22574532
[TBL] [Abstract][Full Text] [Related]
14. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis.
Varadarajulu S; Tamhane A; Eloubeidi MA
Gastrointest Endosc; 2005 Nov; 62(5):728-36; quiz 751, 753. PubMed ID: 16246688
[TBL] [Abstract][Full Text] [Related]
15. Effect of pancreatic juice cytology and/or endoscopic ultrasound-guided fine-needle aspiration biopsy for pancreatic tumor.
Matsumoto K; Takeda Y; Harada K; Horie Y; Yashima K; Murawaki Y
J Gastroenterol Hepatol; 2014 Jan; 29(1):223-7. PubMed ID: 23869654
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic ultrasound-guided pancreatic fine-needle aspiration: potential pitfalls in one institution's experience of 1212 procedures.
Bergeron JP; Perry KD; Houser PM; Yang J
Cancer Cytopathol; 2015 Feb; 123(2):98-107. PubMed ID: 25410732
[TBL] [Abstract][Full Text] [Related]
17. Detection of KRAS gene mutations in endoscopic ultrasound-guided fine-needle aspiration biopsy for improving pancreatic cancer diagnosis.
Wang X; Gao J; Ren Y; Gu J; Du Y; Chen J; Jin Z; Zhan X; Li Z; Huang H; Lv S; Gong Y
Am J Gastroenterol; 2011 Dec; 106(12):2104-11. PubMed ID: 21876563
[TBL] [Abstract][Full Text] [Related]
18. EUS-guided FNA diagnostic yield of malignancy in solid pancreatic masses: a benchmark for quality performance measurement.
Savides TJ; Donohue M; Hunt G; Al-Haddad M; Aslanian H; Ben-Menachem T; Chen VK; Coyle W; Deutsch J; DeWitt J; Dhawan M; Eckardt A; Eloubeidi M; Esker A; Gordon SR; Gress F; Ikenberry S; Joyce AM; Klapman J; Lo S; Maluf-Filho F; Nickl N; Singh V; Wills J; Behling C
Gastrointest Endosc; 2007 Aug; 66(2):277-82. PubMed ID: 17643700
[TBL] [Abstract][Full Text] [Related]
19. EUS-FNA with rescue fluorescence in situ hybridization for the diagnosis of pancreatic carcinoma in patients with inconclusive on-site cytopathology results.
Kubiliun N; Ribeiro A; Fan YS; Rocha-Lima CM; Sleeman D; Merchan J; Barkin J; Levi J
Gastrointest Endosc; 2011 Sep; 74(3):541-7. PubMed ID: 21752364
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis.
Bournet B; Souque A; Senesse P; Assenat E; Barthet M; Lesavre N; Aubert A; O'Toole D; Hammel P; Levy P; Ruszniewski P; Bouisson M; Escourrou J; Cordelier P; Buscail L
Endoscopy; 2009 Jun; 41(6):552-7. PubMed ID: 19533561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]